Previous close | 0.3183 |
Open | 0.3345 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.3345 - 0.3345 |
52-week range | 0.2400 - 0.8860 |
Volume | |
Avg. volume | 19,272 |
Market cap | 17.617M |
Beta (5Y monthly) | 0.31 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2500 |
Earnings date | 13 Feb 2024 - 19 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.96 |
TORONTO, March 20, 2024--ANTIBE TO PRESENT OTENAPROXESUL PK/PD RESULTS AT THE ASRA PAIN MEDICINE MEETING
TORONTO, March 07, 2024--ANTIBE TO PRESENT OTENAPROXESUL PK/PD RESULTS AT THE AMERICAN ACADEMY OF PAIN MEDICINE MEETING
TORONTO, March 04, 2024--Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma